Beyond Air, Inc. (XAIR) stock
XAIRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3084% below fair value
$2.01−0.01 (-0.50%)
Close on Nov 17, 2026Market cap $1.92MP/E –Yield –
Beyond Air ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Beyond Air's ebitda for the twelve months ending Jun 30, 2026 was -$24.84M. For fiscal 2026 it was -$25.94M. The highest annual figure on record is -$11.03M in fiscal 2017.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$25.94M | – |
| FY2025 | Mar 31, 2025 | -$41.54M | – |
| FY2024 | Mar 31, 2024 | -$61.21M | – |
| FY2023 | Mar 31, 2023 | -$51.46M | – |
| FY2022 | Mar 31, 2022 | -$40.40M | – |
| FY2021 | Mar 31, 2021 | -$22.04M | – |
| FY2020 | Mar 31, 2020 | -$18.06M | – |
| FY2017 | Dec 31, 2017 | -$11.03M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$5.81M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$6.37M | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$5.80M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$6.86M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$6.82M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$6.37M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$10.15M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$12.03M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$12.88M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$12.02M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$16.56M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$17.14M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$15.57M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$13.83M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$13.81M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$12.52M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$11.32M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$20.31M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$7.42M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$6.14M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$6.53M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$4.96M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$5.52M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$4.93M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$6.56M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$5.24M | -318.8% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$4.71M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$4.25M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$3.86M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $2.39M | – |
See a number that looks wrong?